Seoul, South Korea

Young Sam Kim

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Aribio Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Sam Kim. Retrieved from https://idiyas.com/inventor/young-sam-kim-g7t2jx1d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Sam Kim: Innovator in Lipid Nanomaterials

Introduction

Young Sam Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of lipid nanomaterials, particularly through his innovative patent that addresses critical health issues.

Latest Patents

Young Sam Kim holds a patent for a lipid nanomaterial containing lysophosphatidylcholine or a derivative thereof. This invention relates to a method for preparing the lipid nanomaterial, which can be utilized to reduce erythrocyteolysis and hemagglutination. The pharmaceutical agent derived from this lipid nanomaterial has potential applications in treating septicemia and bacterial infections. He has 1 patent to his name.

Career Highlights

Throughout his career, Young Sam Kim has worked with notable companies, including Aribio Co., Ltd. and Aribio Inc. His work has been instrumental in advancing research and development in the field of nanotechnology and pharmaceuticals.

Collaborations

Young Sam Kim has collaborated with esteemed colleagues such as Jai Jun Choung and Myung Hwa Kim. Their combined expertise has contributed to the success of various projects and innovations.

Conclusion

Young Sam Kim's contributions to lipid nanomaterials and his innovative patent highlight his role as a key figure in the field of pharmaceuticals. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…